Federal Supply Schedule 36F79722D0178

Award Date 8/1/22
Last Date to Order 7/31/27
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DP18D0006 is a single-award indefinite delivery contract issued by the U.S. Department of Defense (DoD) Medical Supply Chain to the pharmaceutical company Glaxosmithkline, LLC. The contract, valued at a ceiling of $27,848,725.95, enables the DoD to order influenza virus vaccines and other pharmaceutical products from Glaxosmithkline, a foreign-owned for-profit organization, over the term of the agreement. Task orders issued under the IDV provide for the firm...
The federal contract IDV award is for the procurement of pediatric flu vaccines by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian agency. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that specializes in vaccines, antiviral medications, and other medical countermeasures. The contract has a ceiling value of $182,592,000.00 and a period of performance from December 31, 2024 to February 28, 2026. It is a multiple award,...
The federal contract IDV award is an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to Glaxosmithkline Holdings (Americas) Inc. The contract, identified as HHSD200200930521I, has a ceiling value of $809,252,070.00 and a period of performance from July 1, 2009 to June 30, 2010. The contract, known as VFA 2009, does not have any set-asides and was awarded as a multiple-award vehicle....
This federal contract IDV award to Glaxosmithkline, LLC from the Department of Veterans Affairs (VA) National Acquisition Center procures influenza vaccines for use by the VA, Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center. The contract has a total estimated annual usage of 306,829 vaccine doses across various product types including 10-dose vials, pre-filled pediatric syringes, and pre-filled syringes for adults 36 months and...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Alvogen, Inc., a pharmaceutical manufacturer, for the supply of various pharmaceutical and medical products under the Pharmaceuticals and Drugs FSS (FSS-61-IB). The contract has a ceiling value of $32,885,990.00 and an ultimate completion date of May 31, 2026. Under this IDV, the agency has awarded a firm fixed-price delivery order to Alvogen, Inc. for the supply of...
The federal contract IDV with ID HHSO100201500010C was awarded to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency. The single-award indefinite delivery contract, which does not have a set-aside, has a ceiling value of $78,310,394.13 and a period of performance ending on July 22, 2025. The purpose of this contract is to provide the government with a broad range of...
The federal contract IDV award is a $13,916,000 Indefinite Delivery Contract issued by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC to provide adult influenza vaccines for the 2025-2026 season. The contract has a period of performance through February 28, 2026. GlaxoSmithKline, a pharmaceutical company that supplies vaccines and other products to federal agencies, will deliver the seasonal flu vaccines under this multiple award IDV contract. The contract vehicle...
The federal contract IDV award is a Federal Supply Schedule contract with the Department of Veterans Affairs to provide pharmaceutical and hematology-related products. The 5-year, $250,000 multiple award IDV enables VA medical centers in Veterans Integrated Service Network 12 to procure hematology products without separate solicitations. The prime contractor is 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and commercializes infectious disease medicines. 60...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a component of the U.S. Department of Veterans Affairs (VA), to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor. The contract, which has a ceiling value of $5,914,559,260, covers a wide range of pharmaceutical products, including tablets and capsules for conditions such as diabetes, heartburn, infections, and viral...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...

The federal contract IDV is a multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs (VA) for the procurement of pharmaceutical products, medical supplies, and vaccines. The contract has a total ceiling value of $3.9 billion and a period of performance through July 31, 2027. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that provides a range of medical products to various federal agencies.

Under this IDV, Glaxosmithkline has been awarded several delivery orders to supply influenza vaccines, antiviral medications, and other pharmaceutical goods to agencies such as the Department of State, Federal Bureau of Investigation, Department of the Army, and VA. The delivery orders are primarily firm fixed-price contracts, with values ranging from $29,768 to $8.7 million. The products are delivered to locations across the United States, supporting federal immunization programs, disease prevention efforts, and pharmaceutical stockpiling for emergency preparedness. Glaxosmithkline also holds a single-award Blanket Purchase Agreement with the VA National Acquisition Center for the procurement of the pharmaceutical product FLOLAN, valued up to $299,605 over 3 years.

Generated 6/3/25, 10:02 AM